A boy of Mediterranean descent develops dark urine and jaundice 2 days after eating fava beans. He had a similar episode after taking sulfamethoxazole.
XLR; G6PD, encoding glucose 6-phosphate dehydrogenase, the red cell's source of NADPH. Common variants lower enzyme activity, mostly by making the enzyme unstable, and none abolishes it, since complete loss would be lethal.
- Common variants: A- (African), Mediterranean, Asian
The enzyme gives red cells reducing power in the form of NADPH. In a deficient red cell that supply is just adequate in the steady state, which is why the blood is normal between episodes. An oxidative challenge such as primaquine or dapsone lowers NADPH and then depletes glutathione. Once glutathione is gone, the sulfhydryl groups of hemoglobin oxidize and denatured hemoglobin precipitates as Heinz bodies; hemichromes also form and bind band 3, irreversibly damaging the membrane. The most damaged cells probably lyse in the bloodstream (hemoglobinuria, the dark urine) and the rest are removed by macrophages (jaundice).
None of the common variants abolishes the enzyme. Most make it unstable, so the normal fall in enzyme activity as red cells age is greatly accelerated: the oldest cells lyse first, and a younger population with more enzyme survives an episode. Residual activity is about 5% of normal with the Mediterranean variant and 13% with the A- variant, and the same primaquine dose caused more severe hemolysis with the Mediterranean variant. Heterozygous females have two red cell populations through X inactivation, so their hemolysis ranges from almost undetectable to as severe as a hemizygous male's.
- Most common enzyme deficiency worldwide
- Episodic hemolysis triggered by oxidative stress
- Triggers: Fava beans, sulfonamides, antimalarials, infections
- Bite cells, Heinz bodies on smear (during crisis)
- Neonatal jaundice
- Quantitative G6PD enzyme activity assay (spectrophotometric): the standard diagnostic test
- Test when not in acute crisis: young reticulocytes have higher enzyme activity and can mask deficiency, giving false-normal results during hemolysis
- Confirmatory G6PD molecular testing identifies the specific variant (A-, Mediterranean, etc.)
- Carrier detection in heterozygous females can be unreliable by enzyme assay due to X-inactivation; molecular testing is preferred
- Avoid triggers, supportive care during crises